Article: Imitrex Injection And Tablets Proven Effective In Difficult-To-Treat Menstrually-Associated Migraine

 
 Studies Show Relief Available for Most Prevalent, Disabling Type of Migraine 
 
 
 

SAN FRANCISCO, June 26 /PRNewswire/ -- Imitrex(R) (sumatriptan succinate) Injection and Imitrex(R) Tablets have proven effective in relieving migraine associated with the menstrual period, according to clinical studies being presented this week at the annual meeting of the American Association for the Study of Headache (AASH).

Although men do experience migraine, three times more women suffer from the disease, primarily due to the influence of hormones throughout their reproductive years. Among the 18 million women migraine sufferers in the United States, an estimated ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!